Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/jspui/handle/123456789/7744
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiranda, Pedro Henrique de Amorim-
dc.contributor.authorMonteiro, Otávio Montovanelli-
dc.contributor.authorRossoni Júnior, Joamyr Victor-
dc.contributor.authorSilva, Marcelo Eustáquio-
dc.contributor.authorLima, Wanderson Geraldo de-
dc.contributor.authorCosta, Daniela Caldeira-
dc.date.accessioned2017-05-16T17:43:17Z-
dc.date.available2017-05-16T17:43:17Z-
dc.date.issued2015-
dc.identifier.citationMIRANDA, P. H. de A. et al. Vildagliptin induces β-Cell neogenesis and Improves the lipid profile in a later phase of type 1 diabetes. Current Pharmaceutical Biotechnology, v. 16, p. 60-65, 2015. Disponível em: <http://www.eurekaselect.com/126092/article>. Acesso em: 21 mar. 2017.pt_BR
dc.identifier.issn1873-4316-
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/7744-
dc.description.abstractRecently, the inhibitor dipeptidyl peptidase-4 has been reported to be beneficial in the treatment of type 1 diabetes mellitus. For the first time, this study evaluates the effect of vildagliptin on β -cell neogenesis and lipid homeostasis in a later phase of type 1 diabetes. In Fischer rats, diabetes was induced with alloxan. After confirmation of diabetic status, the animals received no treatment for 30 days to establish a late phase of the disease these animals. After this period, the animals were treated with vildagliptin via gavage for 30 consecutive days. Fasting blood glucose, serum insulin, lipid profile and pancreatic histology were evaluated. Treatment with vildagliptin increased serum levels of insulin, improved beta cell function and improved the lipid profile. Histological analyses revealed that this treatment increased the populations of pancreatic β-cells in the diabetic animals. The treatment was effective in improving the mass and function of β-cells and contributed to lipid homeostasis, in an experimental model of type 1 diabetes.pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectβ-cellspt_BR
dc.subjectLipid profilept_BR
dc.subjectNeogenesispt_BR
dc.titleVildagliptin induces β-Cell neogenesis and Improves the lipid profile in a later phase of type 1 diabetes.pt_BR
dc.typeArtigo publicado em periodicopt_BR
dc.identifier.uri2http://www.eurekaselect.com/126092/articlept_BR
dc.identifier.doihttps://doi.org/10.2174/1389201015666141113124341-
Appears in Collections:DEALI - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_VildagliptinInducesCell.pdf
  Restricted Access
1,2 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.